Cramer weighs in on Goldman amid CEO succession talks — plus, Boeing bounces back

Major U.S. equity indexes traded muted despite lower oil prices and stable bonds, as weak Conference Board consumer confidence, retail concerns and unfavorable AI-safety headlines weighed on sentiment. The S&P Oscillator moved further into oversold territory while the 10-year Treasury yield remained near 5%, a level CNBC Investing Club cited as an obstacle to a sustained market rebound. Boeing rebounded after a nearly 7% decline tied to an FAA-related 737 Max 10 certification delay; Bank of America estimated a nine-month delay could reduce free cash flow by $750 million, though it characterized the impact as manageable. Goldman Sachs fell about 1% amid reported succession discussions, while Oura delayed its IPO, for which Goldman is a co-lead.

Analysis

The more investable signal is not the single-session equity weakness but the failure of lower energy prices to relieve pressure on consumer-exposed equities. That implies investors are discounting weaker real demand and/or a higher-for-longer discount rate rather than an input-cost shock. Over the next 1-3 months, this favors quality defensives with recurring demand and pricing power over discretionary retail; PEP is relatively insulated, while KR requires evidence that traffic and private-label mix are offsetting any basket-size pressure.

BA's certification risk is less about the near-term cash-flow estimate than about delivery sequencing, customer compensation, and credibility. A further delay could push narrowbody capacity scarcity into 2027, improving pricing and utilization for airlines but also raising cancellation/deferral leverage for airline customers. BA can rally tactically on reduced uncertainty, but the equity's multiple will remain constrained until management quantifies delivery cadence, inventory rework, and supplier recovery; this is a 6-18 month execution story rather than a clean dip-buy.

For GS, succession headlines are largely noise unless they coincide with a change in capital-return targets, compensation intensity, or the investment-banking recovery. The more relevant second-order issue is the delayed IPO calendar: fewer large listings postpone underwriting and equity-financing fees, while preserving pent-up issuance that can create a stronger 2027 revenue comparison. Consensus may be too focused on headline AI safety concerns; the market implication is modest unless model delays translate into materially slower enterprise AI spending, which would show first in hyperscaler capex commentary and software bookings rather than broad-market sentiment.

Technically oversold conditions can support a days-to-weeks rebound, but sustained upside needs a decline in long-end yields or upward earnings revisions. A rebound driven only by positioning is an opportunity to reduce cyclical beta, not evidence that consumer or duration-sensitive risks have cleared. Falsification: a decisive 10-year yield break lower alongside improving consumer-expectations data would warrant rotating back into cyclicals and broad financials.

Key Decisions for Investors

• Maintain a 1-3 month defensive tilt: long PEP versus short a discretionary-retail basket (XRT) rather than outright PEP. Target 5-8% relative return if consumer data deteriorate; exit if consumer-expectations readings recover for two consecutive monthly prints and XRT relative strength turns higher.
• Do not add strategic BA exposure before management provides revised Max 10 certification and delivery assumptions. For a tactical position only, buy a 3-6 month defined-risk call spread after confirmation that the FAA timeline is unchanged; risk is a new software or production disclosure, which should trigger immediate exit rather than averaging down.
• Keep GS as a core financials preference over BAC for the next 6-12 months, but hedge with a modest XLF short if the 10-year yield remains elevated. GS has greater operating leverage to an eventual capital-markets reopening, while BAC retains more sensitivity to deposit costs and rate-path uncertainty; reassess if IPO and M&A fee pipelines fail to improve by the next two earnings cycles.
• Treat any broad oversold rally over the next 2-4 weeks as a beta-reduction window. Add duration-sensitive equity exposure only after the 10-year yield falls materially and holds below its recent range, or earnings revisions turn positive; absent either, the risk/reward remains unfavorable for chasing NFLX or broad growth beta.